{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:29:00Z","timestamp":1790810940177,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes for Health Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.vaccine.2010.12.012","type":"journal-article","created":{"date-parts":[[2010,12,23]],"date-time":"2010-12-23T09:24:27Z","timestamp":1293096267000},"page":"1519-1526","source":"Crossref","is-referenced-by-count":28,"title":["Divergence of immunologic and protective responses of different BCG strains in a murine model"],"prefix":"10.1016","volume":"29","author":[{"given":"R.","family":"Kozak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Behr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"April 9517","key":"10.1016\/j.vaccine.2010.12.012_bib0005","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(06)68507-3","article-title":"Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness","volume":"367","author":"Trunz","year":"2006","journal-title":"Lancet"},{"issue":"September (Suppl. 3)","key":"10.1016\/j.vaccine.2010.12.012_bib0010","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1086\/314072","article-title":"Preventing tuberculosis with bacillus Calmette-Guerin vaccine: a meta-analysis of the literature","volume":"31","author":"Brewer","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"September 5","key":"10.1016\/j.vaccine.2010.12.012_bib0015","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.tube.2007.05.016","article-title":"Rv1773 is a transcriptional repressor deleted from BCG-Pasteur","volume":"87","author":"Alexander","year":"2007","journal-title":"Tuberculosis (Edinb)"},{"issue":"June 5","key":"10.1016\/j.vaccine.2010.12.012_bib0020","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1111\/j.1365-2958.2005.04618.x","article-title":"Reduced expression of antigenic proteins MPB70 and MPB83 in Mycobacterium bovis BCG strains due to a start codon mutation in sigK","volume":"56","author":"Charlet","year":"2005","journal-title":"Mol Microbiol"},{"issue":"May 5","key":"10.1016\/j.vaccine.2010.12.012_bib0025","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1128\/IAI.72.5.2803-2809.2004","article-title":"Impact of methoxymycolic acid production by Mycobacterium bovis BCG vaccines","volume":"72","author":"Belley","year":"2004","journal-title":"Infect Immun"},{"issue":"February 2","key":"10.1016\/j.vaccine.2010.12.012_bib0030","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1128\/IAI.71.2.708-716.2003","article-title":"Mycobacterium bovis BCG vaccines exhibit defects in alanine and serine catabolism","volume":"71","author":"Chen","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2010.12.012_bib0035","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1186\/1471-2164-9-413","article-title":"Novel genome polymorphisms in BCG vaccine strains and impact on efficacy","volume":"9","author":"Leung","year":"2008","journal-title":"BMC Genomics"},{"issue":"November 48","key":"10.1016\/j.vaccine.2010.12.012_bib0040","doi-asserted-by":"crossref","first-page":"8114","DOI":"10.1016\/j.vaccine.2007.09.041","article-title":"Differential productions of lipid virulence factors among BCG vaccine strains and implications on BCG safety","volume":"25","author":"Chen","year":"2007","journal-title":"Vaccine"},{"issue":"October 27\u201330","key":"10.1016\/j.vaccine.2010.12.012_bib0045","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1016\/S0264-410X(03)00484-5","article-title":"The in vitro evolution of BCG vaccines","volume":"21","author":"Mostowy","year":"2003","journal-title":"Vaccine"},{"issue":"May 5419","key":"10.1016\/j.vaccine.2010.12.012_bib0050","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1126\/science.284.5419.1520","article-title":"Comparative genomics of BCG vaccines by whole-genome DNA microarray","volume":"284","author":"Behr","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2010.12.012_bib0055","first-page":"107","article-title":"BCG complications. Estimates of the risks among vaccinated subjects and statistical analysis of their main characteristics","volume":"21","author":"Lotte","year":"1984","journal-title":"Adv Tuberc Res"},{"issue":"February 2","key":"10.1016\/j.vaccine.2010.12.012_bib0060","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1128\/IAI.63.2.672-675.1995","article-title":"Relationship of secretion pattern and MPB70 homology with osteoblast-specific factor 2 to osteitis following Mycobacterium bovis BCG vaccination","volume":"63","author":"Ulstrup","year":"1995","journal-title":"Infect Immun"},{"issue":"January 1","key":"10.1016\/j.vaccine.2010.12.012_bib0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/IAI.64.1.1-9.1996","article-title":"Comparison of immune responses of mice immunized with five different Mycobacterium bovis BCG vaccine strains","volume":"64","author":"Lagranderie","year":"1996","journal-title":"Infect Immun"},{"issue":"May 5","key":"10.1016\/j.vaccine.2010.12.012_bib0070","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1128\/CVI.00018-08","article-title":"Immune response induced by three Mycobacterium bovis BCG substrains with diverse regions of deletion in a C57BL\/6 mouse model","volume":"15","author":"Irwin","year":"2008","journal-title":"Clin Vaccine Immunol"},{"issue":"January 3","key":"10.1016\/j.vaccine.2010.12.012_bib0075","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.vaccine.2008.10.058","article-title":"Commonly administered BCG strains including an evolutionarily early strain and evolutionarily late strains of disparate genealogy induce comparable protective immunity against tuberculosis","volume":"27","author":"Horwitz","year":"2009","journal-title":"Vaccine"},{"issue":"March 6","key":"10.1016\/j.vaccine.2010.12.012_bib0080","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1128\/JB.01452-07","article-title":"Evolution of the mycobacterial SigK regulon","volume":"190","author":"Veyrier","year":"2008","journal-title":"J Bacteriol"},{"issue":"November 10","key":"10.1016\/j.vaccine.2010.12.012_bib0085","doi-asserted-by":"crossref","first-page":"7157","DOI":"10.4049\/jimmunol.181.10.7157","article-title":"NOD2-deficient mice have impaired resistance to Mycobacterium tuberculosis infection through defective innate and adaptive immunity","volume":"181","author":"Divangahi","year":"2008","journal-title":"J Immunol"},{"issue":"September 7004","key":"10.1016\/j.vaccine.2010.12.012_bib0090","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nature02837","article-title":"A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response","volume":"431","author":"Reed","year":"2004","journal-title":"Nature"},{"issue":"April 1","key":"10.1016\/j.vaccine.2010.12.012_bib0095","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1128\/IAI.52.1.293-302.1986","article-title":"Properties of proteins MPB64, MPB70, and MPB80 of Mycobacterium bovis BCG","volume":"52","author":"Harboe","year":"1986","journal-title":"Infect Immun"},{"issue":"June 6","key":"10.1016\/j.vaccine.2010.12.012_bib0100","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1046\/j.1365-3083.1996.d01-260.x","article-title":"Human T-cell epitopes on the Mycobacterium tuberculosis secreted protein MPT64","volume":"43","author":"Roche","year":"1996","journal-title":"Scand J Immunol"},{"issue":"October 13","key":"10.1016\/j.vaccine.2010.12.012_bib0105","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/0264-410X(93)90096-G","article-title":"Oral immunization with recombinant BCG induces cellular and humoral immune responses against the foreign antigen","volume":"11","author":"Lagranderie","year":"1993","journal-title":"Vaccine"},{"issue":"August 8","key":"10.1016\/j.vaccine.2010.12.012_bib0110","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1128\/IAI.70.8.4501-4509.2002","article-title":"Dissemination of Mycobacterium tuberculosis is influenced by host factors and precedes the initiation of T-cell immunity","volume":"70","author":"Chackerian","year":"2002","journal-title":"Infect Immun"},{"issue":"Decemer 6","key":"10.1016\/j.vaccine.2010.12.012_bib0115","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1084\/jem.178.6.2243","article-title":"Disseminated tuberculosis in interferon gamma gene-disrupted mice","volume":"178","author":"Cooper","year":"1993","journal-title":"J Exp Med"},{"issue":"December 6","key":"10.1016\/j.vaccine.2010.12.012_bib0120","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1084\/jem.178.6.2249","article-title":"An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection","volume":"178","author":"Flynn","year":"1993","journal-title":"J Exp Med"},{"issue":"December 12","key":"10.1016\/j.vaccine.2010.12.012_bib0125","doi-asserted-by":"crossref","first-page":"e1000239","DOI":"10.1371\/journal.ppat.1000239","article-title":"Innate invariant NKT cells recognize Mycobacterium tuberculosis-infected macrophages, produce interferon-gamma, and kill intracellular bacteria","volume":"4","author":"Sada-Ovalle","year":"2008","journal-title":"PLoS Pathog"},{"issue":"7","key":"10.1016\/j.vaccine.2010.12.012_bib0130","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1128\/CVI.00067-09","article-title":"Development of a murine mycobacterial growth inhibition assay for evaluating vaccines against Mycobacterium tuberculosis","volume":"16","author":"Parra","year":"2009","journal-title":"Clin Vaccine Immunol"},{"issue":"September 6647","key":"10.1016\/j.vaccine.2010.12.012_bib0135","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/38151","article-title":"Has BCG attenuated to impotence?","volume":"389","author":"Behr","year":"1997","journal-title":"Nature"},{"issue":"March 13","key":"10.1016\/j.vaccine.2010.12.012_bib0140","doi-asserted-by":"crossref","first-page":"5596","DOI":"10.1073\/pnas.0700869104","article-title":"Genome plasticity of BCG and impact on vaccine efficacy","volume":"104","author":"Brosch","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2010.12.012_bib0145","doi-asserted-by":"crossref","DOI":"10.1111\/j.1574-695X.2009.00559.x","article-title":"Comparable studies of immunostimulating activities in vitro among Mycobacterium bovis bacillus Calmette-Guerin (BCG) substrains","author":"Hayashi","year":"2009","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"October 44","key":"10.1016\/j.vaccine.2010.12.012_bib0150","doi-asserted-by":"crossref","first-page":"6179","DOI":"10.1016\/j.vaccine.2009.08.018","article-title":"Fusion protein Ag85B-MPT64(190-198)-Mtb8.4 has higher immunogenicity than Ag85B with capacity to boost BCG-primed immunity against Mycobacterium tuberculosis in mice","volume":"27","author":"Luo","year":"2009","journal-title":"Vaccine"},{"issue":"April 4","key":"10.1016\/j.vaccine.2010.12.012_bib0155","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1365-3083.2009.02231.x","article-title":"More vaccine efficacy studies on the recombinant Bacille Calmette-Guerin co-expressing Ag85B, Mpt64 and Mtb8. 4","volume":"69","author":"Qie","year":"2009","journal-title":"Scand J Immunol"},{"issue":"December 12","key":"10.1016\/j.vaccine.2010.12.012_bib0160","doi-asserted-by":"crossref","first-page":"5202","DOI":"10.1128\/IAI.00267-10","article-title":"Surface expression of MPT64 as a fusion with the PE domain of PE_PGRS33 enhances Mycobacterium bovis BCG protective activity against Mycobacterium tuberculosis in mice","volume":"78","author":"Sali","year":"2010","journal-title":"Infect Immun"},{"issue":"December 12","key":"10.1016\/j.vaccine.2010.12.012_bib0165","doi-asserted-by":"crossref","first-page":"4613","DOI":"10.1128\/IAI.63.12.4613-4618.1995","article-title":"Mapping of the delayed-type hypersensitivity-inducing epitope of secreted protein MPT64 from Mycobacterium tuberculosis","volume":"63","author":"Oettinger","year":"1995","journal-title":"Infect Immun"},{"issue":"July 7","key":"10.1016\/j.vaccine.2010.12.012_bib0170","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.1128\/IAI.66.7.3454-3456.1998","article-title":"Delayed-type hypersensitivity responses to ESAT-6 and MPT64 from Mycobacterium tuberculosis in the guinea pig","volume":"66","author":"Elhay","year":"1998","journal-title":"Infect Immun"},{"issue":"November 11","key":"10.1016\/j.vaccine.2010.12.012_bib0175","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1348-0421.2008.00072.x","article-title":"Immunoreactivity of five antigens of Mycobacterium tuberculosis in patients attending a public health care facility in an area with high endemicity for TB","volume":"52","author":"Silva","year":"2008","journal-title":"Microbiol Immunol"},{"issue":"April 4","key":"10.1016\/j.vaccine.2010.12.012_bib0180","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/ni1449","article-title":"IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge","volume":"8","author":"Khader","year":"2007","journal-title":"Nat Immunol"},{"issue":"September 3","key":"10.1016\/j.vaccine.2010.12.012_bib0185","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1165\/rcmb.2004-0213OC","article-title":"Interleukin-17 as a recruitment and survival factor for airway macrophages in allergic airway inflammation","volume":"33","author":"Sergejeva","year":"2005","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"June 12","key":"10.1016\/j.vaccine.2010.12.012_bib0190","doi-asserted-by":"crossref","first-page":"4408","DOI":"10.4049\/jimmunol.138.12.4408","article-title":"Mycobacterial growth inhibition by interferon-gamma-activated bone marrow macrophages and differential susceptibility among strains of Mycobacterium tuberculosis","volume":"138","author":"Flesch","year":"1987","journal-title":"J Immunol"},{"issue":"June 12","key":"10.1016\/j.vaccine.2010.12.012_bib0195","doi-asserted-by":"crossref","first-page":"7569","DOI":"10.4049\/jimmunol.0800296","article-title":"Involvement of CD252 (CD134L) and IL-2 in the expression of cytotoxic proteins in bacterial- or viral-activated human T cells","volume":"182","author":"Walch","year":"2009","journal-title":"J Immunol"},{"issue":"February 4","key":"10.1016\/j.vaccine.2010.12.012_bib0200","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.4049\/jimmunol.172.4.2171","article-title":"Disparate in vitro and in vivo requirements for IL-2 during antigen-independent CD8 T cell expansion","volume":"172","author":"Wong","year":"2004","journal-title":"J Immunol"},{"issue":"July 33","key":"10.1016\/j.vaccine.2010.12.012_bib0205","doi-asserted-by":"crossref","first-page":"4412","DOI":"10.1016\/j.vaccine.2009.05.048","article-title":"Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis","volume":"27","author":"Sun","year":"2009","journal-title":"Vaccine"},{"issue":"July 1","key":"10.1016\/j.vaccine.2010.12.012_bib0210","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1164\/ajrccm.154.1.8680692","article-title":"Does the protective effect of neonatal BCG vaccination correlate with vaccine-induced tuberculin reactions?","volume":"154","author":"Comstock","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"issue":"July 30","key":"10.1016\/j.vaccine.2010.12.012_bib0215","doi-asserted-by":"crossref","first-page":"12434","DOI":"10.1073\/pnas.0703510104","article-title":"Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosis","volume":"104","author":"Mittrucker","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"issue":"March 3","key":"10.1016\/j.vaccine.2010.12.012_bib0220","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1128\/IAI.74.3.1718-1724.2006","article-title":"Mycobacterium bovis BCG substrains confer different levels of protection against Mycobacterium tuberculosis infection in a BALB\/c model of progressive pulmonary tuberculosis","volume":"74","author":"Castillo-Rodal","year":"2006","journal-title":"Infect Immun"},{"issue":"April 4","key":"10.1016\/j.vaccine.2010.12.012_bib0225","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1128\/IAI.71.4.1672-1679.2003","article-title":"A new vaccine against tuberculosis affords greater survival after challenge than the current vaccine in the guinea pig model of pulmonary tuberculosis","volume":"71","author":"Horwitz","year":"2003","journal-title":"Infect Immun"},{"issue":"December 25","key":"10.1016\/j.vaccine.2010.12.012_bib0230","doi-asserted-by":"crossref","first-page":"13853","DOI":"10.1073\/pnas.250480397","article-title":"Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model","volume":"97","author":"Horwitz","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.vaccine.2010.12.012_bib0235","doi-asserted-by":"crossref","first-page":"325","DOI":"10.4049\/jimmunol.48.5.325","article-title":"The effect of paraffin oil lanolin-like substances and killed tubercle bacilli on immunization with diphtheric toxoid and Bact. Typhosum","volume":"48","author":"Freund","year":"1944","journal-title":"J Immunol"},{"issue":"August 8","key":"10.1016\/j.vaccine.2010.12.012_bib0240","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1084\/jem.20081779","article-title":"Increased NOD2-mediated recognition of N-glycolyl muramyl dipeptide","volume":"206","author":"Coulombe","year":"2009","journal-title":"J Exp Med"},{"issue":"December 13","key":"10.1016\/j.vaccine.2010.12.012_bib0245","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1084\/jem.20091750","article-title":"Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin Mincle","volume":"206","author":"Ishikawa","year":"2009","journal-title":"J Exp Med"},{"issue":"February 8","key":"10.1016\/j.vaccine.2010.12.012_bib0250","doi-asserted-by":"crossref","first-page":"5513","DOI":"10.1074\/jbc.C200586200","article-title":"The cell surface receptor DC-SIGN discriminates between Mycobacterium species through selective recognition of the mannose caps on lipoarabinomannan","volume":"278","author":"Maeda","year":"2003","journal-title":"J Biol Chem"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10017500?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10017500?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T16:06:32Z","timestamp":1685894792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10017500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":50,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0264410X10017500"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.12.012","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}